EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access

Sustained Virological Response as a Surrogate Marker for Mortality, Decompensated Cirrhosis, or Hepatocellular Carcinoma in People With Chronic Hepatitis C Virus Infection Treated With Direct-Acting Antivirals: Protocol for a Bayesian and Causal Mediation Analysis

Kurinchi Selvan Gurusamy iD, Christian Gluud iD

JMIR Research Protocols · 2025

DOI: 10.2196/68113 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift JMIR Research Protocols, 2025. Verfasst von Kurinchi Selvan Gurusamy und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Surgery and Interventional Science, University College London, London, United Kingdom. Hauptthemen laut MEDLINE: Hepatitis C, Chronic, Antiviral Agents, Carcinoma, Hepatocellular, Liver Cirrhosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sustained virological response (SVR) is commonly used as a marker of treatment success in people with chronic hepatitis C virus (HCV) infection. However, there is uncertainty on whether SVR is a validated surrogate marker of successful chronic HCV infection treatment.

Objective

This research project aims to evaluate whether SVR is a good surrogate for all-cause mortality, decompensated cirrhosis, any specific aspect of liver decompensation (jaundice, ascites, hepatic encephalopathy, hepatorenal syndrome, or variceal hemorrhage), or hepatocellular carcinoma in people with chronic HCV infection eligible to receive direct-acting antiviral drugs.

Methods

We will use two ongoing systematic reviews on the effectiveness of direct-acting antiviral drugs in chronic HCV infection as our data sources. The analysis plan is to estimate the regression coefficients or between-studies correlation between SVR and an event using three different Bayesian approaches with OpenBUGS, as outlined in the guidance by the evidence synthesis unit, and estimate the average proportion of the effect mediated through SVR by causal mediation analysis using R.

Results

As of June 19, 2025, the two systematic reviews (one on randomized clinical trials and one on observational studies) on the effectiveness of direct-acting antiviral drugs in chronic HCV infection are ongoing.

Conclusions

We will use the German Institute of Quality and Efficiency in Health Care criterion for surrogacy for cancer, with at least 50% of the treatment effect mediated through SVR, but the information will be reported in a way that allows people to interpret the information using their own criteria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis C, ChronicAntiviral AgentsCarcinoma, HepatocellularLiver CirrhosisLiver NeoplasmsSustained Virologic ResponseHumansBayes TheoremBiomarkersMediation AnalysisSystematic Reviews as TopicHepacivirus

Stichwörter der Autor:innen

HCVSVRchronic hepatitis C infectiondirect-acting antiviral drugssurrogate outcomesustained virological response

Substanzen

Antiviral AgentsBiomarkers

Autor:innen und Institutionen

  • Division of Surgery and Interventional Science, University College London, London, United Kingdom.
  • Cochrane Hepato-Biliary Group, Copenhagen, Denmark.
  • The Copenhagen Trial Unit, Copenhagen, Denmark.
  • Department of Regional Health Research, Odense, Denmark.

ORCID-Profile: Kurinchi Selvan Gurusamy, Christian Gluud

Zitieren

APA

Gurusamy, K. S., & Gluud, C. (2025). Sustained Virological Response as a Surrogate Marker for Mortality, Decompensated Cirrhosis, or Hepatocellular Carcinoma in People With Chronic Hepatitis C Virus Infection Treated With Direct-Acting Antivirals: Protocol for a Bayesian and Causal Mediation Analysis. JMIR Research Protocols. https://doi.org/10.2196/68113

Vancouver

Gurusamy KS, Gluud C. Sustained Virological Response as a Surrogate Marker for Mortality, Decompensated Cirrhosis, or Hepatocellular Carcinoma in People With Chronic Hepatitis C Virus Infection Treated With Direct-Acting Antivirals: Protocol for a Bayesian and Causal Mediation Analysis. JMIR Research Protocols. 2025. doi:10.2196/68113

BibTeX
@article{Gurusamy2025,
  author = {Gurusamy, Kurinchi Selvan and Gluud, Christian},
  title = {Sustained Virological Response as a Surrogate Marker for Mortality, Decompensated Cirrhosis, or Hepatocellular Carcinoma in People With Chronic Hepatitis C Virus Infection Treated With Direct-Acting Antivirals: Protocol for a Bayesian and Causal Mediation Analysis},
  journal = {JMIR Research Protocols},
  year = {2025},
  doi = {10.2196/68113}
}
Kostenlos starten →